The Psychedelic Renaissance Has a Cultural Story
Over the past decade, psychedelic-assisted therapies have re-emerged as powerful tools in mental health treatment. Ketamine-assisted psychotherapy (KAP), MDMA-assisted therapy for post-traumatic stress disorder (PTSD), and psilocybin-assisted therapy for depression are now at the forefront of innovative trauma treatment. Clinical studies suggest that these therapies may support emotional processing, neuroplasticity, and trauma integration in ways that differ from traditional psychiatric treatments (Drozdz et al., 2022; Sessa et al., 2019).
Yet beneath this scientific renaissance lies a deeper truth: many of these healing traditions are not new.
Long before Western psychiatry began studying psychedelic substances in clinical trials, Indigenous communities across the world had already developed sophisticated ceremonial healing practices involving plant medicines. Ayahuasca ceremonies in the Amazon, peyote rituals among Native American communities, and psilocybin mushroom traditions in Mesoamerican cultures represent only a few examples of longstanding cultural medicine traditions.
Today, as Western medicine integrates psychedelic therapies into clinical settings, an important question emerges:
How can modern psychotherapy integrate these approaches ethically without erasing the cultures that preserved them?
Decolonizing psychedelic therapy requires more than scientific innovation—it requires cultural humility, ethical reflection, and an expanded understanding of healing.
What Does “Decolonizing Therapy” Mean?
Decolonization in mental health involves examining how Western systems have historically marginalized or appropriated non-Western healing traditions. Psychology and psychiatry have often framed Western medical models as the dominant authority on mental health, while Indigenous healing systems were dismissed or misunderstood (Halstead et al., 2021).
Within psychedelic research, this dynamic has become increasingly visible. Many psychedelic substances now studied in clinical trials originate from Indigenous ceremonial contexts, yet the communities that preserved these practices have frequently been excluded from research leadership and decision-making (Cornfield et al., 2024).
Decolonizing therapy asks clinicians and researchers to reflect on important questions:
-
Who is considered an expert in healing?
-
Whose knowledge is valued in clinical research?
-
Who has access to emerging treatments?
Addressing these questions is essential as psychedelic therapy continues to develop within modern mental health care systems.
Psychedelics Have Always Been Relational
One of the most profound differences between traditional Indigenous healing practices and Western psychedelic therapy lies in the relational context of healing.
In many Indigenous ceremonial settings, healing is understood as occurring within a network of relationships—including relationships with community, ancestors, nature, and spiritual traditions. Healing is rarely conceptualized as an individual psychological process alone.
By contrast, Western psychotherapy historically focused on the individual mind and internal psychological processes. While trauma research has increasingly acknowledged the relational nature of healing, including the importance of attachment and interpersonal safety, the cultural context of healing is still often overlooked (Van der Kolk, 2014; Mikulincer & Shaver, 2016).
Integrative therapy models that combine trauma treatment, relational repair, and emerging modalities such as ketamine-assisted psychotherapy may begin to bridge this gap. These approaches recognize that trauma affects not only individual neurobiology but also relational and social systems (Drozdz et al., 2022).
Cultural Humility in Psychedelic Therapy
Cultural humility is a core ethical principle when working with culturally rooted healing practices. Unlike cultural competence—which suggests that clinicians can master knowledge about other cultures—cultural humility recognizes that learning is ongoing and that therapists must remain open to perspectives beyond their own training (Halstead et al., 2021).
For clinicians working with psychedelic therapies, cultural humility may include several practices.
Acknowledging the Origins of Psychedelic Medicines
Many psychedelic substances studied in clinical trials today originate from Indigenous medicine traditions. Acknowledging this history helps prevent cultural erasure and encourages respect for the communities that preserved these practices.
For example, peyote has deep spiritual significance within Native American Church traditions, while psilocybin mushrooms have long been used in Mesoamerican spiritual ceremonies (Cornfield et al., 2024).
Recognizing this history allows therapists to approach psychedelic therapies with greater awareness of their cultural context.
Avoiding Cultural Appropriation
Another ethical challenge in the psychedelic wellness space is the commercialization of Indigenous rituals without cultural context. Retreat centers and wellness industries sometimes adopt ceremonial language or practices without cultural lineage or accountability.
This phenomenon raises ethical concerns about cultural appropriation and exploitation.
Mental health professionals can respond to this challenge by avoiding imitation of ceremonial traditions outside their training and by supporting Indigenous voices in psychedelic research and policy discussions (Halstead et al., 2021).
Expanding Access to Healing
A third issue in psychedelic therapy involves access to care. Many psychedelic treatments—particularly ketamine therapy—are expensive and geographically limited.
As a result, psychedelic treatments often remain accessible primarily to affluent populations, despite the fact that trauma disproportionately affects marginalized communities.
Expanding access to psychedelic therapy requires systemic changes such as community partnerships, inclusive research practices, and advocacy for equitable mental health care systems (Drozdz et al., 2022).
Trauma, Culture, and Collective Healing
Trauma is frequently discussed as an individual psychological experience. However, trauma can also occur collectively through historical events such as colonization, racism, displacement, and systemic oppression.
Historical trauma research suggests that these experiences can shape the emotional and psychological wellbeing of entire communities across generations (Van der Kolk, 2014).
Emerging research on psychedelic therapies suggests that these treatments may facilitate emotional openness, compassion, and perspective shifts that could support collective trauma healing (Sessa et al., 2019).
However, such healing must occur within culturally responsive frameworks that acknowledge the historical and social context of trauma.
Without this awareness, psychedelic therapy risks replicating the same systemic harms it seeks to address.
The Role of Therapists in Ethical Psychedelic Care
Therapists integrating emerging modalities such as ketamine-assisted psychotherapy carry significant ethical responsibility.
Psychedelic therapies involve altered states of consciousness, emotional vulnerability, and powerful neurobiological effects that require careful clinical preparation and integration (Drozdz et al., 2022).
Ethical psychedelic care therefore includes:
-
trauma-informed treatment frameworks
-
culturally responsive practices
-
clear informed consent procedures
-
ongoing therapist training and supervision
These principles align with broader trauma therapy research emphasizing the importance of safety, trust, and relational attunement in healing (Van der Kolk, 2014).
Integrative Healing Requires Multiple Perspectives
Trauma recovery rarely occurs through a single therapeutic approach. Instead, healing often requires interventions that address multiple dimensions of experience, including neurobiological regulation, emotional processing, relational repair, and embodied awareness.
Integrative therapy models that combine attachment theory, trauma processing techniques such as EMDR, and emerging psychedelic modalities aim to address these overlapping systems simultaneously (Drozdz et al., 2022).
Decolonizing therapy expands this integrative framework even further by recognizing that cultural knowledge, community traditions, and spiritual perspectives may also play essential roles in healing.
Moving Toward a More Ethical Psychedelic Future
The psychedelic renaissance represents one of the most significant developments in modern mental health research.
However, innovation alone is not enough.
If psychedelic therapy is to fulfill its healing potential, the field must move beyond purely biomedical models and embrace cultural humility, ethical accountability, and expanded access to care.
Decolonizing psychedelic therapy does not reject scientific research. Rather, it encourages a broader understanding of healing—one that respects cultural knowledge while integrating emerging clinical insights.
When therapy acknowledges both science and cultural wisdom, psychedelic healing can evolve into a more inclusive and ethically grounded future.